BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 25470092)

  • 1. Correlates of incident bipolar disorder in children and adolescents diagnosed with attention-deficit/hyperactivity disorder.
    Jerrell JM; McIntyre RS; Park YM
    J Clin Psychiatry; 2014 Nov; 75(11):e1278-83. PubMed ID: 25470092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for incident major depressive disorder in children and adolescents with attention-deficit/hyperactivity disorder.
    Jerrell JM; McIntyre RS; Park YM
    Eur Child Adolesc Psychiatry; 2015 Jan; 24(1):65-73. PubMed ID: 24705730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental pathways for different subtypes of early-onset bipolarity in youths.
    Masi G; Mucci M; Pfanner C; Berloffa S; Magazù A; Perugi G
    J Clin Psychiatry; 2012 Oct; 73(10):1335-41. PubMed ID: 23058936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparing the comorbidity of attention-deficit/hyperactivity disorder in childhood and adolescence].
    Keresztény A; Dallos G; Miklósi M; Róka A; Gádoros J; Balázs J
    Psychiatr Hung; 2012; 27(3):165-73. PubMed ID: 22781541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comorbidity of attention-deficit/hyperactivity disorder with psychiatric disorder: an overview.
    Pliszka SR
    J Clin Psychiatry; 1998; 59 Suppl 7():50-8. PubMed ID: 9680053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors Associated With Musculoskeletal Injuries in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
    Guy JA; Knight LM; Wang Y; Jerrell JM
    Prim Care Companion CNS Disord; 2016; 18(3):. PubMed ID: 27733957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ADHD with comorbid oppositional defiant disorder or conduct disorder: discrete or nondistinct disruptive behavior disorders?
    Connor DF; Doerfler LA
    J Atten Disord; 2008 Sep; 12(2):126-34. PubMed ID: 17934178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychiatric comorbidity among children and adolescents with and without persistent attention-deficit hyperactivity disorder.
    Gau SS; Ni HC; Shang CY; Soong WT; Wu YY; Lin LY; Chiu YN
    Aust N Z J Psychiatry; 2010 Feb; 44(2):135-43. PubMed ID: 20113302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy patterns and predictors of ADHD in commercially insured and Medicaid populations.
    Molife C; Bernauer MJ; Farr AM; Haynes VS; Kelsey D
    Postgrad Med; 2012 Sep; 124(5):7-22. PubMed ID: 23095422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attention-deficit hyperactivity disorder, its pharmacotherapy, and the risk of developing bipolar disorder: A nationwide population-based study in Taiwan.
    Wang LJ; Shyu YC; Yuan SS; Yang CJ; Yang KC; Lee TL; Lee SY
    J Psychiatr Res; 2016 Jan; 72():6-14. PubMed ID: 26519764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Externalizing disorders in consecutively referred children and adolescents with bipolar disorder.
    Masi G; Toni C; Perugi G; Travierso MC; Millepiedi S; Mucci M; Akiskal HS
    Compr Psychiatry; 2003; 44(3):184-9. PubMed ID: 12764705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and diagnostic implications of lifetime attention-deficit/hyperactivity disorder comorbidity in adults with bipolar disorder: data from the first 1000 STEP-BD participants.
    Nierenberg AA; Miyahara S; Spencer T; Wisniewski SR; Otto MW; Simon N; Pollack MH; Ostacher MJ; Yan L; Siegel R; Sachs GS;
    Biol Psychiatry; 2005 Jun; 57(11):1467-73. PubMed ID: 15950022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic Treatment Among Youths With Attention-Deficit/Hyperactivity Disorder.
    Sultan RS; Wang S; Crystal S; Olfson M
    JAMA Netw Open; 2019 Jul; 2(7):e197850. PubMed ID: 31348506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attention-deficit hyperactivity disorder -- bipolar comorbidity in children and adolescents.
    Masi G; Perugi G; Toni C; Millepiedi S; Mucci M; Bertini N; Pfanner C
    Bipolar Disord; 2006 Aug; 8(4):373-81. PubMed ID: 16879138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recognizing and managing bipolar disorder in children.
    Wozniak J
    J Clin Psychiatry; 2005; 66 Suppl 1():18-23. PubMed ID: 15693748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.
    Kollins SH
    Curr Med Res Opin; 2008 May; 24(5):1345-57. PubMed ID: 18384709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating bipolar disorder in Turkish prepubertal children with attention-deficit hyperactivity disorder.
    Diler RS; Uguz S; Seydaoglu G; Erol N; Avci A
    Bipolar Disord; 2007 May; 9(3):243-51. PubMed ID: 17430299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder.
    Bond DJ; Hadjipavlou G; Lam RW; McIntyre RS; Beaulieu S; Schaffer A; Weiss M;
    Ann Clin Psychiatry; 2012 Feb; 24(1):23-37. PubMed ID: 22303520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.